Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 497

1.

Tight glycemic control may favor fibrinolysis in patients with sepsis.

Savioli M, Cugno M, Polli F, Taccone P, Bellani G, Spanu P, Pesenti A, Iapichino G, Gattinoni L.

Crit Care Med. 2009 Feb;37(2):424-31. doi: 10.1097/CCM.0b013e31819542da.

PMID:
19114908
2.

Activation of the fibrinolytic system and utilization of the coagulation inhibitors in sepsis: comparison with severe sepsis and septic shock.

Mavrommatis AC, Theodoridis T, Economou M, Kotanidou A, El Ali M, Christopoulou-Kokkinou V, Zakynthinos SG.

Intensive Care Med. 2001 Dec;27(12):1853-9.

PMID:
11797019
3.

Early inhibition of activated fibrinolysis predicts microbial infection, shock and mortality in febrile medical patients.

Raaphorst J, Johan Groeneveld AB, Bossink AW, Erik Hack C.

Thromb Haemost. 2001 Aug;86(2):543-9.

PMID:
11522001
4.

Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock.

Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, Strauss R, Meier-Hellmann A, Insel R, Radke J, Schüttler J, Gärtner R.

Crit Care Med. 2007 Jan;35(1):118-26.

PMID:
17095947
5.

Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit.

Clayton SB, Mazur JE, Condren S, Hermayer KL, Strange C.

Crit Care Med. 2006 Dec;34(12):2974-8.

PMID:
17075371
6.

Association between early glycemic control and improvements in markers of coagulation and fibrinolysis in patients with septic shock-induced stress hyperglycemia.

Sanches LC, Pontes Azevedo LC, Salomão R, Noguti MA, Brunialti M, Lourenço DM, Machado FR.

J Crit Care. 2014 Oct;29(5):884.e1-6. doi: 10.1016/j.jcrc.2014.04.019.

PMID:
24891151
7.

TAFI and PAI-1 levels in human sepsis.

Zeerleder S, Schroeder V, Hack CE, Kohler HP, Wuillemin WA.

Thromb Res. 2006;118(2):205-12.

PMID:
16009400
8.

[Glycemic control in sepsis and septic shock: friend or foe?].

Ellger B, Westphal M, Stubbe HD, Van den Heuvel I, Van Aken H, Van den Berghe G.

Anaesthesist. 2008 Jan;57(1):43-8. Review. German.

PMID:
18034219
9.

Time course and prognostic significance of hemostatic changes in sepsis: relation to tumor necrosis factor-alpha.

Martínez MA, Peña JM, Fernández A, Jiménez M, Juárez S, Madero R, Vázquez JJ.

Crit Care Med. 1999 Jul;27(7):1303-8.

PMID:
10446824
10.

Effects of recombinant human activated protein C on the fibrinolytic system of patients undergoing conventional or tight glycemic control.

Polli F, Savioli M, Cugno M, Taccone P, Bellani G, Spanu P, Pesenti A, Iapichino G, Gattinoni L.

Minerva Anestesiol. 2009 Jul-Aug;75(7-8):417-26.

11.

The role of strict metabolic control by insulin infusion on fibrinolytic profile during an acute coronary event in diabetic patients.

Melidonis A, Stefanidis A, Tournis S, Manoussakis S, Handanis S, Zairis M, Dadiotis L, Foussas S.

Clin Cardiol. 2000 Mar;23(3):160-4.

12.

Impact of tight glycemic control on cerebral glucose metabolism after severe brain injury: a microdialysis study.

Oddo M, Schmidt JM, Carrera E, Badjatia N, Connolly ES, Presciutti M, Ostapkovich ND, Levine JM, Le Roux P, Mayer SA.

Crit Care Med. 2008 Dec;36(12):3233-8. doi: 10.1097/CCM.0b013e31818f4026.

PMID:
18936695
13.
14.

Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock.

Sundén-Cullberg J, Nyström T, Lee ML, Mullins GE, Tokics L, Andersson J, Norrby-Teglund A, Treutiger CJ.

Crit Care Med. 2007 Jun;35(6):1536-42.

PMID:
17452927
15.

Increase of plasminogen activator inhibitor levels predicts outcome of leukocytopenic patients with sepsis.

Mesters RM, Flörke N, Ostermann H, Kienast J.

Thromb Haemost. 1996 Jun;75(6):902-7.

PMID:
8822584
16.

The vasopressin and copeptin response to infection, severe sepsis, and septic shock.

Jochberger S, Dörler J, Luckner G, Mayr VD, Wenzel V, Ulmer H, Morgenthaler NG, Hasibeder WR, Dünser MW.

Crit Care Med. 2009 Feb;37(2):476-82. doi: 10.1097/CCM.0b013e3181957532.

PMID:
19114902
17.

Effect of long-term and high-dose antithrombin supplementation on coagulation and fibrinolysis in patients with severe sepsis.

Hoffmann JN, Mühlbayer D, Jochum M, Inthorn D.

Crit Care Med. 2004 Sep;32(9):1851-9.

PMID:
15343012
18.

Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock.

Gando S, Nanzaki S, Sasaki S, Aoi K, Kemmotsu O.

Crit Care Med. 1998 Dec;26(12):2005-9.

PMID:
9875912
19.

Sepsis severity is the major determinant of circulating thrombopoietin levels in septic patients.

Zakynthinos SG, Papanikolaou S, Theodoridis T, Zakynthinos EG, Christopoulou-Kokkinou V, Katsaris G, Mavrommatis AC.

Crit Care Med. 2004 Apr;32(4):1004-10.

PMID:
15071393
20.
Items per page

Supplemental Content

Support Center